Bruker Corporation (BRKR) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BRKR Revenue Growth
Revenue Breakdown (FY 2024)
BRKR's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
BRKR Revenue Analysis (2013–2024)
As of May 6, 2026, Bruker Corporation (BRKR) generated trailing twelve-month (TTM) revenue of $3.44 billion, reflecting slight decline in growth of -0.2% year-over-year. The most recent quarter (Q4 2025) recorded $977.2 million in revenue, up 13.6% sequentially.
Looking at the longer-term picture, BRKR's 5-year compound annual growth rate (CAGR) stands at +10.2%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $3.37 billion in 2024, representing a new all-time high.
Revenue diversification analysis shows BRKR's business is primarily driven by Product (82%), and Product and Service, Other (18%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including WAT (+26.4% YoY), TRMB (-2.6% YoY), and FTV (-23.4% YoY), BRKR has underperformed the peer group in terms of revenue growth. Compare BRKR vs WAT →
BRKR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BRKRCurrent | $3.4B | -0.2% | +10.2% | 7.5% | |
 WAT | $3.2B | +26.4% | +6.0% | 28.2% | |
 TRMB | $3.6B | -2.6% | +2.6% | 16.9% | |
 FTV | $5.1B | -23.4% | +2.1% | 17.7% | |
 A | $6.9B | +8.1% | +5.4% | 21.3% | |
 TMO | $44.6B | +5.4% | +6.7% | 18.2% |
BRKR Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $3.37B | +13.6% | $1.65B | 49.0% | $253.1M | 7.5% |
| 2023 | $2.96B | +17.1% | $1.51B | 51.0% | $436.9M | 14.7% |
| 2022 | $2.53B | +4.7% | $1.31B | 51.6% | $432.7M | 17.1% |
| 2021 | $2.42B | +21.7% | $1.21B | 50.0% | $413.3M | 17.1% |
| 2020 | $1.99B | -4.1% | $939.8M | 47.3% | $248.3M | 12.5% |
| 2019 | $2.07B | +9.3% | $995.3M | 48.0% | $300.9M | 14.5% |
| 2018 | $1.90B | +7.3% | $900.0M | 47.5% | $262.4M | 13.8% |
| 2017 | $1.77B | +9.6% | $813.0M | 46.0% | $214.7M | 12.2% |
| 2016 | $1.61B | -0.8% | $742.5M | 46.1% | $177.2M | 11.0% |
| 2015 | $1.62B | -10.2% | $708.6M | 43.6% | $145.7M | 9.0% |
See BRKR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BRKR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BRKR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBRKR — Frequently Asked Questions
Quick answers to the most common questions about buying BRKR stock.
Is BRKR's revenue growth accelerating or slowing?
BRKR revenue growth slowed to -0.2%, below the 5-year CAGR of +10.2%. TTM revenue is $3.4B. The deceleration marks a shift from historical growth rates.
What is BRKR's long-term revenue growth rate?
Bruker Corporation's 5-year revenue CAGR of +10.2% reflects the variable expansion pattern. Current YoY growth of -0.2% is near this long-term average.
How is BRKR's revenue distributed by segment?
BRKR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.